Soleno Therapeutics, Inc. (SLNO) has a market capitalization of $2.72B and trades at $52.62. The 52-week range is 29.43-90.32.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 128.3, Earnings Per Share (EPS) of $0.41, annual revenue of $190.41M.
The stock has a beta of -2.81, operates in the Healthcare sector.
